Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee

Journal of Rheumatology

Volumn 27, Issue 3, 2000, Pages 764-771

  Peloso, Paul M ^e   Bellamy, Nicholas ^a   Bensen, William ^b   Thomson, Glen T D ^f   Harsanyi, Zoltan ^c   Babul, Najib ^d   Darke, Andrew C ^c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

^c Department of Scientific Affairs ^*  (Canada)

^d ROYAL UNIVERSITY HOSPITAL   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

^f ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Codeine; Controlled release; Osteoarthritis; Randomized clinical trial; WOMAC

Indexed keywords

CODEINE; CODEINE CONTIN; PLACEBO; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ACETAMINOPHEN; AGED; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; CODEINE; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PLACEBOS; PLIABILITY; SLEEP;

EID: 0034064578     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Bellamy N, Bradley L. Workshop on chronic pain, pain control, and patient outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1996;39:357-62.
2. Hochberg M, Altman R, Brandt K, et al. Guidelines for the medical management of osteoarthritis. Arthritis Rheum 1995;38:1535-46.
3. Tannenbaum H, Davis P, Russell A, et al. An evidence-based approach to prescribing NSAID's in musculoskeletal disease: A Canadian consensus [review]. Can Med Assoc J 1996;155:77-88.
4. Peloso P. Degenerative joint disease. Therapeutic Choices. Ottawa: Canadian Pharmaceutical Association; 1995:338-43.
5. Bradley J, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325:87-91.
6. Wilcox CM, Shalek KA, Cotsonis G. Striking prevalence of over-the-counter nonsteroidal antiinflammatory drug use in patients with unper gastrointestinal hemorrhage. Arch Intern Med 1994;154:42-5.
7. Guthann S, Rodriguez G, Raiford D. Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 1997; 8:18-24.
8. Soil AH, Weinstein WM, Kurata J, McCarthy D, Nonsteroidal antiinflammatory drugs and peptic ulcer disease. Ann Intern Med 1991;114:307-19.
9. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984;310:563-72.
10. Perneger TV, Wheiton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994;331:1675-9.
11. Segasothy M, Suleiman AB, Puvaneswary M, Rohanna A. Paracetamol: a cause for analgesic nephropathy and end-stage renal disease. Nephron 1988;50:50-4.
12. Sandier DP, Smith JC, Weinberg CR, et al. Analgesic use of chronic renal disease. N Engl J Med 1989;320:1238-43.
13. Jacox AK, Carr DB, Payne R, et al. Management of cancer pain, clinical practice guideline. 9. Rockville, MD: Agency for Health Care Policy and Research; 1994 (AHCPR Publ. No. 94-D592).
14. Levy MH. Pharmacologic treatment of cancer pain. New Engl J Med 1996;335:1124-32.
15. Portenoy R. Opioid therapy for chronic nonmalignant pain: current status. Pain Res Manage 1994;1:247-87.
16. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic non-malignant pain. J Pain Symptom Manage 1992;7:69-77.
17. Schofferman J. Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage 1993;7:279-88.
18. France RD, Urban BJ, Keefe FJ. Long term use of narcotic analgesics in chronic pain. Soc Sci Med 1984;19:1379-82.
19. Moulin DE, lezzi A, Amireh R, Sharpe WKJ, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:143-7.
20. Arkinstall W, Sandler A, Goughnour B, Babul N, Harsanyi Z, Darke A. Efficacy of controlled release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain 1995;62:169-78.
21. Hale ME, Speigth KL, Harsanyi Z, et al. Efficacy of 12 hourly controlled-release codeine compared with as required dosing of acetaminophen plus codeine in patients with chronic low back pain. Pa Res Manage 1997;2:33-8.
22. Anonymous. Guidelines for the management of chronic non-malignant pain, February 1993. Bulletin of the College of Physicians and Surgeons of Alberta, 15 March 1993, Edmonton, Alberta.
23. Goldman B. A physician's guide to chronic opioid therapy. The Can J CME 1997;9:71-9.
24. Dieppe P. Therapeutic targets in osteoarthritis. J Rheumatol 1995;43:136-9.
25. Muskowitz RW. Clinical and laboratory findings in osteoarthritis. In: McCarty DJ, editor. Arthritis and allied conditions. A textbook of rheumatology, 11th ed. Philadelphia: Lea and Febiger; 1989: Ch. 102.
26. Stein C, Comisel K, Haimeri E, et al. Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N Engl J Med 1991;325:1123-6.
27. Khoury GF, Chen AC, Geriand DE, Stein C. Intraarticular morphine, bupivacaine, and morphine/bupivacaine for pain control after knee videoarthroscopy. Anesthesiology 1992;77:263-6.
28. Joshi GP, McCarroll SM, O'Brien TM, Lenane P. Intra-articular analgesia following knee arthroscopy. Anesth Analg 1993;76:333-6.
29. De Andres J, Beliver J, Barrera L, Febre E, Bolinches R. A comparative study of analgesia after knee surgery with intraarticular bupivacaine, intraarticular morphine, and lumbar plexus block. Anesth Analg 1993;77:727-30.
30. Haynes TK, Appadurai IR, Power I, Rosen M, Grant A. Intraarticular morphine and bupivacaine analgesia after arthroscopic knee surgery. Anesthesia 1994;49:54-6.
31. Heine MF, Tillet ED, Tsueda K, et al. Intra-articular morphine after arthroscopic knee operations. Br J Anaesthesiol 1994;73:413-5.
32. Dalsgaard J, Felsby S, Juelsgaard P, Froekjaer J. Low-dose intra-articular morphine analgesia in day care knee arthroscopy: a randomized double-blinded prospective study. Pain 1994;56:151-4.
33. Ferrel B, Wisdom C, Wenzl C, Bown J. Effects of controlled-release morphine on quality of life for cancer pain. Oncol Nurs Forum 1989;16:521-6.
34. Band CJ, Band PR, Deschamps M, Besner J, Goldman A. Human pharmacokinetic study of immediate release (codeine phosphate) and sustained-release (Codeine Contin) codeine. J Clin Pharmacol 1994;34:938-43.
35. Chary S, Goughnour BR, Moulin DE, Thorpe WR. Harsanyi Z, Darke AC. The dose-response relationship of controlled-release codeine (Codeine Contin) in chronic cancer pain. J Pain Symptom Manage 1994;9:363-71.
36. Atlas of standard radiographs. The epidemiology of chronic rheumatism. Vol 2. Philadelphia: F.A. Davis; 1963.
37. Bellamy N, Buchanan W, Goldsmith C. Campbell J, Stilt L. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-49.
38. Bellamy N. Pain assessment in osteoarthritis. Experience with the WOMAC osteoarthritis index. Semin Arthritis Rheum 1989; 18:14-7.
39. Jasinski DR. Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In: Martin WR, editor. Drug addiction. I. Morphine, sedative hypnotic and alcohol dependence. Handb Exp Pharmacol 1977;45:197-258.
40. Bellamy N, Carette S, Ford PM, et al. Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials - results of a consensus development (Delphi) exercise. J Rheumatol 1992;19:451-7.
41. Bellamy N, Kean WF, Buchanan WW, Gereez-Simon E, Campbell J. Double-blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren); Post-validation reapplication of the WOMAC Osteoarthritis Index. J Rheumatol 1992;19:153-9.
42. Bellamy N, Carette S, Ford PM, et al. Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials. J Rheumatol 1992;19:444-50.
43. Bellamy N, Buchanan WW, Chalmers A, et al. A multicentre study of tenoxicam and diclofenac in patients with Osteoarthritis of the knee. J Rheumatol 1993;20:999-1004.
44. Ytterherg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 1998;41:1603-12.
45. Lacouture P, Roth S, Burch F, Fleischmann R, Iwan T, Kaiko R. A double-blind, placebo-controlled, repeated dose, dose-response evaluation of controlled-release (CR) oxycodone in patients with Osteoarthritis. Clin Pharmacol Therapeutics 1996;59:129.
46. Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled-release oxycodone or fixed-combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: A double-blind, randomized, multicenter, placebo-controlled trial. J Rheumatol 1999;26:862-9.
47. Gertzbein SD, Tile M, McMurty RY, et al. Analysis of the analgesic-efficacy of acetaminophen 100 mg, codeine phosphate 60 mg, and the combination of acetaminophen 100 mg and codeine phosphate 60 mg in the relief of postoperative pain. Pharmacotherapy 1986;6:104-7.
48. Quiding H, Grimstad J, Rusten K, Stubhaug A, Bremnes J, Breivik H. Ibuprofen plus codeine, ibuprofen, and placebo in a single dose and multidose cross-over comparison for coxarthrosis pain. Pain 1992;50:303-7.
49. Holman GH. Chronic nonmalignant pain. Clin Geriatr 1997; 5:21-41.
50. Stein C. The control of pain in peripheral tissues by opioids. New Engl J Med 1995;332:1685-90.
51. Hargreaves KM, Joris JL. The peripheral analgesic effects of opioids. Am Pain Soc J 1993;2:51-9.
52. Stein C, Hassan AHS, Lehrberger K. Giefing J, Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 1993;342:321-4.
53. Barber A, Gottschlich R. Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation. Med Res Rev 1992;12:525-62.